Table 4

Heaviest participants (body-weight ≥ 100 kg) initiating smoking at ≤ 20 years: relative risk of hospital-treated pneumonia by vitamin E supplementation



Intervention
Effect of vitamin E



Vitamin E
No vitamin E


Subgroup
No. of participants
No. of cases
No. of cases
RR (95% CI)*
P-value for interaction

All
1226
20
7
3.10 (1.30–7.4)

BMI †





     < median
613
8
4
2.18 (0.64–7.4)
0.3
     ≥ median
613
12
3
4.66 (1.30–16.7)

Height †





     < median
593
11
5
2.19 (0.75–6.3)
0.4
     ≥ median
633
9
2
5.50 (1.11–27.1)

Dietary vitamin E †





     < median
613
11
4
3.00 (0.94–9.5)
0.9
     ≥ median
613
9
3
3.85 (0.93–15.9)

Dietary vitamin C †





     < median
613
8
6
1.37 (0.46–4.0)
0.019
     ≥ median
613
12
1
14.5 (1.84–114.5)

Residual of fruit, vegetables, berries †





     < median
613
12
4
3.55 (1.13–11.2)
0.8
     ≥ median
613
8
3
2.65 (0.69–10.1)

β-Carotene supplementation





     No
622
10
3
3.23 (0.89–11.8)
0.9
     Yes
604
10
4
3.90 (1.10–13.8)


* Proportional hazards regression model comparing participants who received vitamin E with those who did not. The regression models were adjusted for age, baseline smoking, intake of coffee and alcohol, BMI and employment. Participants with missing data on confounders (n = 102) are excluded from this table. The sizes of all compared intervention groups are the same within 15% accuracy. RR, risk ratio; CI, confidence interval.

† The medians for the high-weight group are: weight 106.0 kg; BMI 33.5 kg/m2; height 179 cm; dietary vitamin E intake 12.4 mg/day; dietary vitamin C intake 95.5 mg/day; residual of fruit, vegetable, and berry intake -4.8 g/day.

Hemilä and Kaprio Nutrition Journal 2008 7:33   doi:10.1186/1475-2891-7-33